Advertisement

Bariatric Surgery and Stone Disease: Help or Hindrance?

  • Gautam Jayram
  • Brian R. MatlagaEmail author
Chapter

Abstract

Obesity is an important medical problem that is rapidly approaching epidemic status. As diet and lifestyle changes can be ineffective at producing long-term weight loss, bariatric surgical procedures have become increasingly applicable to the management of obesity. Recent evidence suggests that certain types of bariatric procedures will induce lithogenic metabolic changes, and have been associated with increased risk of kidney stone formation. Specifically, Roux-en-Y gastric bypass procedures appear most likely to increase risk of urinary stone disease. In these patients, identification of metabolic abnormalities is important to therapeutically modify these risk factors. In doing so, the likelihood of stone formation may be reduced.

Keywords

Urolithiasis Gastric bypass Obesity Metabolic stone disease 

References

  1. 1.
    American Heart Association. Statistical Fact Sheet Update. http://www.heart.org/idc/groups/heart-public/@wcm/@sop/@smd/documents/downloadable/ucm_319588.pdf (June 10, 2013).
  2. 2.
    Roth J, Qiang X, Marban SL, Redelt H, Lowell BC. The obesity pandemic: where have we been and where are we going? Obes Res 2004;12:88.CrossRefGoogle Scholar
  3. 3.
    Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. JAMA. 2005;293:455.PubMedCrossRefGoogle Scholar
  4. 4.
    Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States, 1976–1994. Kidney Int. 2004;63:1817.CrossRefGoogle Scholar
  5. 5.
    Curhan GC Willett WC, Rimm EB, Speizer FE, Stampfer MJ. Body size and risk of kidney stones. J Am Soc Nephrol. 1998;9:1645.PubMedGoogle Scholar
  6. 6.
    NIH Conference. Gastrointestinal surgery for severe obesity. Consensus development conference panel. Ann Intern Med. 1991;115:956.CrossRefGoogle Scholar
  7. 7.
    Glenny AM, O’Meara S, Melville A, Sheldon TA, Wilson C. The treatment and prevention of obesity: a systematic review of the literature. Int J Obes Relat Metab Disord. 1997;21:715–37.PubMedCrossRefGoogle Scholar
  8. 8.
    Santry HP, Gillen DL, Lauderdale DS. Trends in bariatric surgical procedures. JAMA. 2005;294:1909.PubMedCrossRefGoogle Scholar
  9. 9.
    West B, Luke A, Durzao-Arvizu RA, Cao G, Shoham D, Kramer H. Metabolic syndrome and self-reported history of kidney stones: the national health and nutrition examination survey (NHANES III) 1988–1994. Am J Kidney Dis. 2008;51:741–7.PubMedCrossRefGoogle Scholar
  10. 10.
    Rendina D, Mossetti G, De Filippo G, Benvenuto D, Vivona CL, Imbroinise A, et al. Association between metabolic syndrome and nephrolithiasis in an inpatient population in southern Italy: role of gender, hypertension, and abdominal obesity. Nephrol Dial Transplant. 2009;24:900–6.PubMedCrossRefGoogle Scholar
  11. 11.
    Semins MJ, Shore AD, Makary MA, Magnuson T, Johns R, Matlaga BR. The association of increasing body mass index and kidney stone disease. J Urol. 2010 Feb; 183(2):571–5.PubMedCentralPubMedCrossRefGoogle Scholar
  12. 12.
    Duffey BG, Pedro RN, Kriedberg C, Weiland D, Melquist J, Ikramuddin S, et al. Lithogenic risk factors in the morbidly obese population. J Urol. 2008;179:1401.PubMedCrossRefGoogle Scholar
  13. 13.
    Maalouf NM, Sakhaee K, Parks JH, Coe FL, Adams-Huet B, Pak CY. Association of urinary pH with body weight in nephrolithiasis. Kidney Int. 2004;65:1422–5.PubMedCrossRefGoogle Scholar
  14. 14.
    Taylor EN, Curhan GC. Body size and 24-hour urine composition. Am J Kidney Dis. 2006;48:905–15.PubMedCrossRefGoogle Scholar
  15. 15.
    Abate N, Chandalia M, Cabo-Can AV Jr, et al. The metabolic syndrome and uric acid nephrolithiasis: novel features of renal resistance. Kidney Int 2004;65:386–92.PubMedCrossRefGoogle Scholar
  16. 16.
    Cappuccio FP, Strazzullo P, Mancini M, Moe OW, Sakhaee K. Kidney stones and hypertension: an independent clinical association in a population based study. BMJ 1990;300:1234–6.PubMedCrossRefGoogle Scholar
  17. 17.
    Ekeruo WO, Tan YH, Young MD, Dahm P, Maloney ME, Mathias BJ, et al. Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients. J Urol. 2005;172:159.CrossRefGoogle Scholar
  18. 18.
    Kirkpatrik JR. Jejunoileal bypass. A legacy of late complications. Arch Surg 1987;122:610–4.CrossRefGoogle Scholar
  19. 19.
    Nelson Andersson H, Bosaeus I. Hyperoxaluria in malabsorptive states. Urol Int 1981;36:1–9.CrossRefGoogle Scholar
  20. 20.
    Requarth JA, Burchard KW, Colacchio TA, Stukel TA, Mott LA, Greenberg ER, et al. Long-term morbidity following jejunoileal bypass. The continuing potential need for surgical reversal. Arch Surg. 1995;130:318.PubMedCrossRefGoogle Scholar
  21. 21.
    Belachew M, Legrand M, Vincent V, Lismonde M, Le Docte N, Deschamps V. Laparoscopic adjustable gastric banding. World J Surg 1998;22:955.PubMedCrossRefGoogle Scholar
  22. 22.
    Nguyen NT, Masoomi H, Magno CP, Nguyen XM, Laugenour K, Lane J. Trends in use of bariatric surgery, 2003–2008. J Am Coll Surg. 2011 Aug;213(2):261–6.PubMedCrossRefGoogle Scholar
  23. 23.
    Hinojosa MW, Vareal JE, Parikh D, Smith BR, Nguyen XM, Nguyen NT. National trends in use and outcome of laparoscopic adjustable gastric banding. Surg Obes Relat Dis. 2009;5:150–155.PubMedCrossRefGoogle Scholar
  24. 24.
    Semins MJ, Matlaga BR, Shore AD, Steele K, Magnuson T, Johns R, et al. The effect of gastric banding on kidney stone disease. Urology. 2009 Oct;74(4):746–9.PubMedCentralPubMedCrossRefGoogle Scholar
  25. 25.
    Nadler EP, Young HA, Ren CJ, Fielding GA. An update on 73 US obese pediatric patients treated with laparoscopic adjustable gastric banding: comorbidity resolution and compliance data. J Pediatr Surg. 2008 Jan; 43(1):141–6.PubMedGoogle Scholar
  26. 26.
    Chen T, Godebu E, Horgan S, Mirheydar HS, Sur RL. The effect of restrictive bariatric surgery on urolithiasis. J Endourol. 2013 Feb;27(2):242–4.PubMedCrossRefGoogle Scholar
  27. 27.
    Semins MJ, Asplin JR, Steele K, Assimos DG, Lingeman JE, Donahue S, et al. The effect of restrictive bariatric surgery on urinary stone risk factors. Urology. 2010 Oct;76(4):826–9.PubMedCrossRefGoogle Scholar
  28. 28.
    Penniston KL, Kaplon DM, Gould JC, Nakada SY. Gastric band placement for obesity is not associated with increased urinary risk of urolithiasis compared to bypass. J Urol. 2009 Nov;182(5):2340–6.PubMedCrossRefGoogle Scholar
  29. 29.
    Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004;292:1724–37.PubMedCrossRefGoogle Scholar
  30. 30.
    Patriti A, Facchiano E, Sanna A, Gullà N, Donini A. The enteroinsular axis and recovery from type 2 diabetes after bariatric surgery. Obes Surg 2004;14:840–8.PubMedCrossRefGoogle Scholar
  31. 31.
    Asplin JR, Coe FL. Hyperoxaluria in kidney stone formers treated with modern bariatric surgery. J Urol. 2007 177:565–9.PubMedCrossRefGoogle Scholar
  32. 32.
    Wu JN, Craig J, Chamie K, Ali MR, Low RK. Urolithiasis risk factors in the bariatric population undergoing gastric bypass surgery. Surg Obes Relat Dis. 2013 Jan-Feb;9(1)83–7.PubMedCrossRefGoogle Scholar
  33. 33.
    Duffey BG, Alanee S, Pedro RN, Hinck B, Kriedberg C, Ikramuddin S, et al. Hyperoxaluria is a long-term consequence of Roux-en-Y gastric bypass: a 2-year prospective longitudinal study. J Am Coll Surg. 2010 Jul;211(1):8–15.PubMedCrossRefGoogle Scholar
  34. 34.
    Maalouf NM, Tondapu P, Guth ES, Livingston EH, Sakhaee K. Hypocitraturia and hyperoxaluria after Roux-en-Y gastric bypass surgery. J Urol. 2010 Mar;183(3):1026–30.PubMedCentralPubMedCrossRefGoogle Scholar
  35. 35.
    Durrani O, Morrisroe S, Jackman S, Averch T. Analysis of stone disease in morbidly obese patients undergoing gastric bypass surgery. J Endourol. 2006 Oct; 20(10):749–52.PubMedCrossRefGoogle Scholar
  36. 36.
    Matlaga BR, Shore AD, Magnuson JM, Clark JM, Johns R, Makary MA. Effect of gastric bypass surgery on kidney stone disease. J Urol. 2009 Jun;181(6):2573–7.PubMedCrossRefGoogle Scholar
  37. 37.
    Furtado LC. Nutritional management after Roux-en-Y gastric bypass. Br J Nurs. 2010 Apr 8–21;19(7):428–36.PubMedGoogle Scholar
  38. 38.
    Pang R, Linnes MP, O’Conner HM, Li X, Bergstralh E, Lieske JC. Controlled metabolic diet reduces calcium oxalate supersaturation but not oxalate excretion after bariatric surgery. Urology. 2012 Aug;80(2):250–4.PubMedCentralPubMedCrossRefGoogle Scholar
  39. 39.
    Siva S, Barrack ER, Reddy GP, Thamilselvan V, Thamilselvan S, Menon M, et al. A critical analysis of the role of gut Oxalobacter formigenes in oxalate stone disease. BJU Int. 2009 Jan;103(1):18–21.PubMedGoogle Scholar
  40. 40.
    Siener R, Bangen U, Sidhu H, Hönow R, von Unruh G, Hesse A. The role of Oxalobacter formigenes colonization in calcium oxalate stone disease. Kidney Int. 2013 Jun;83(6):1144–9.PubMedCrossRefGoogle Scholar
  41. 41.
    Dhar NB, Grundfest S, Jones JS, Streem SB. Jejunoileal bypass reversal: effect on renal function, metabolic parameters and stone formation. J Urol. 2005 Nov;174(5):1844–6.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.The Johns Hopkins HospitalJames Buchanan Brady Urological InstituteBaltimoreUSA

Personalised recommendations